Company news
Xenon Pharmaceuticals Inc. news in 2019
Xenon Pharmaceuticals Inc.'s news releases, calls and decks from 2019, newest first.
Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting
December 6, 2019
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting
December 5, 2019
Xenon Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference
December 2, 2019
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on License and Collaboration Agreement with Neurocrine Biosciences
December 1, 2019
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
December 1, 2019
Xenon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 4, 2019
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update
October 28, 2019
Xenon Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
September 24, 2019
Xenon Announces Appointment of Shelley McCloskey as Senior Vice President, Human Resources
September 16, 2019
Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain
September 8, 2019